{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:22:52Z","timestamp":1774689772836,"version":"3.50.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["(20202BABL206024)"],"award-info":[{"award-number":["(20202BABL206024)"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11010-023-04832-x","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:02:05Z","timestamp":1693195325000},"page":"1969-1984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LncRNAs in Kawasaki disease and Henoch-Sch\u00f6nlein purpura: mechanisms and clinical applications"],"prefix":"10.1007","volume":"479","author":[{"given":"Kangping","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hejin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"issue":"1","key":"4832_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/1756-185x.13214","volume":"21","author":"JC Burns","year":"2018","unstructured":"Burns JC (2018) History of the worldwide emergence of Kawasaki disease. Int J Rheum Dis 21(1):13\u201315. https:\/\/doi.org\/10.1111\/1756-185x.13214","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"4832_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","volume":"18","author":"RA Watts","year":"2022","unstructured":"Watts RA, Hatemi G, Burns JC, Mohammad AJ (2022) Global epidemiology of vasculitis. Nat Rev Rheumatol 18(1):22\u201334. https:\/\/doi.org\/10.1038\/s41584-021-00718-8","journal-title":"Nat Rev Rheumatol"},{"key":"4832_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jpeds.2018.07.090","volume":"203","author":"SM Skochko","year":"2018","unstructured":"Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J et al (2018) Kawasaki disease outcomes and response to therapy in a multiethnic community: a 10-year experience. J Pediatr 203:408\u201315.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.090","journal-title":"J Pediatr"},{"key":"4832_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fped.2019.00121","volume":"7","author":"YH Huang","year":"2019","unstructured":"Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC (2019) Increased incidence of Kawasaki disease in Taiwan in recent years: a 15 years nationwide population-based cohort study. Front Pediatr 7:121. https:\/\/doi.org\/10.3389\/fped.2019.00121","journal-title":"Front Pediatr"},{"issue":"5","key":"4832_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/inf.0000000000001474","volume":"36","author":"GB Kim","year":"2017","unstructured":"Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL et al (2017) Epidemiology and clinical features of Kawasaki disease in South Korea, 2012\u20132014. Pediatr Infect Dis J 36(5):482\u2013485. https:\/\/doi.org\/10.1097\/inf.0000000000001474","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"4832_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/ped.14164","volume":"62","author":"Y Matsubara","year":"2020","unstructured":"Matsubara Y, Matsubara D, Ae R, Kosami K, Aoyama Y, Yashiro M et al (2020) Cumulative incidence of Kawasaki disease with cardiac sequelae in Japan. Pediatr Int 62(4):444\u2013450. https:\/\/doi.org\/10.1111\/ped.14164","journal-title":"Pediatr Int"},{"key":"4832_CR7","doi-asserted-by":"publisher","first-page":"771619","DOI":"10.3389\/fimmu.2021.771619","volume":"12","author":"Y Song","year":"2021","unstructured":"Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu J et al (2021) Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol 12:771619. https:\/\/doi.org\/10.3389\/fimmu.2021.771619","journal-title":"Front Immunol"},{"issue":"5","key":"4832_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/annrheumdis-2020-218649","volume":"80","author":"M Sapina","year":"2021","unstructured":"Sapina M, Frkovic M, Sestan M, Srsen S, Ovuka A, Batnozic Varga M et al (2021) Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis. Ann Rheum Dis 80(5):610\u2013616. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218649","journal-title":"Ann Rheum Dis"},{"issue":"10239","key":"4832_CR9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/s0140-6736(20)31129-6","volume":"395","author":"RM Viner","year":"2020","unstructured":"Viner RM, Whittaker E (2020) Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 395(10239):1741\u20131743. https:\/\/doi.org\/10.1016\/s0140-6736(20)31129-6","journal-title":"Lancet"},{"issue":"7","key":"4832_CR10","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","volume":"180","author":"L Hoste","year":"2021","unstructured":"Hoste L, Van Paemel R, Haerynck F (2021) Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 180(7):2019\u20132034. https:\/\/doi.org\/10.1007\/s00431-021-03993-5","journal-title":"Eur J Pediatr"},{"issue":"17","key":"4832_CR11","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/cir.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927\u2013e999. https:\/\/doi.org\/10.1161\/cir.0000000000000484","journal-title":"Circulation"},{"key":"4832_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017\u20132018. J Pediatr 225:23\u20139.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.034","journal-title":"J Pediatr"},{"issue":"2","key":"4832_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2188\/jea.je20110131","volume":"22","author":"R Uehara","year":"2012","unstructured":"Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22(2):79\u201385. https:\/\/doi.org\/10.2188\/jea.je20110131","journal-title":"J Epidemiol"},{"key":"4832_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.116.003289","author":"KG Friedman","year":"2016","unstructured":"Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH et al (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.116.003289","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"4832_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jpc.12403","volume":"49","author":"P Trnka","year":"2013","unstructured":"Trnka P (2013) Henoch-Sch\u00f6nlein purpura in children. J Paediatr Child Health 49(12):995\u20131003. https:\/\/doi.org\/10.1111\/jpc.12403","journal-title":"J Paediatr Child Health"},{"issue":"9","key":"4832_CR16","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.38024","volume":"65","author":"D Eleftheriou","year":"2013","unstructured":"Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ et al (2013) Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 65(9):2476\u20132485. https:\/\/doi.org\/10.1002\/art.38024","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4832_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/adc.2009.167874","volume":"95","author":"O Jauhola","year":"2010","unstructured":"Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T et al (2010) Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child 95(11):871\u2013876. https:\/\/doi.org\/10.1136\/adc.2009.167874","journal-title":"Arch Dis Child"},{"issue":"9566","key":"4832_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/s0140-6736(07)60474-7","volume":"369","author":"FT Saulsbury","year":"2007","unstructured":"Saulsbury FT (2007) Clinical update: Henoch-Sch\u00f6nlein purpura. The Lancet 369(9566):976\u2013978. https:\/\/doi.org\/10.1016\/s0140-6736(07)60474-7","journal-title":"The Lancet"},{"issue":"8","key":"4832_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00467-007-0450-1","volume":"22","author":"PA Brogan","year":"2007","unstructured":"Brogan PA (2007) What\u2019s new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22(8):1083\u20131094. https:\/\/doi.org\/10.1007\/s00467-007-0450-1","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4832_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1203\/00006450-200301000-00026","volume":"53","author":"JW Newburger","year":"2003","unstructured":"Newburger JW, Taubert KA, Shulman ST, Rowley AH, Gewitz MH, Takahashi M et al (2003) Summary and abstracts of the Seventh International Kawasaki disease symposium: December 4\u20137, 2001, Hakone, Japan. Pediatr Res 53(1):153\u2013157. https:\/\/doi.org\/10.1203\/00006450-200301000-00026","journal-title":"Pediatr Res"},{"issue":"10","key":"4832_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","volume":"22","author":"E Rife","year":"2020","unstructured":"Rife E, Gedalia A (2020) Kawasaki disease: an update. Curr Rheumatol Rep 22(10):75. https:\/\/doi.org\/10.1007\/s11926-020-00941-4","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"4832_CR22","doi-asserted-by":"publisher","first-page":"e74529","DOI":"10.1371\/journal.pone.0074529","volume":"8","author":"JC Burns","year":"2013","unstructured":"Burns JC, Herzog L, Fabri O, Tremoulet AH, Rod\u00f3 X, Uehara R et al (2013) Seasonality of Kawasaki disease: a global perspective. PLoS ONE 8(9):e74529. https:\/\/doi.org\/10.1371\/journal.pone.0074529","journal-title":"PLoS ONE"},{"issue":"12","key":"4832_CR23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/509509","volume":"194","author":"SR Dominguez","year":"2006","unstructured":"Dominguez SR, Anderson MS, Glod\u00e9 MP, Robinson CC, Holmes KV (2006) Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis 194(12):1697\u20131701. https:\/\/doi.org\/10.1086\/509509","journal-title":"J Infect Dis"},{"issue":"6","key":"4832_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/inf.0b013e31819f41b6","volume":"28","author":"C Lehmann","year":"2009","unstructured":"Lehmann C, Klar R, Lindner J, Lindner P, Wolf H, Gerling S (2009) Kawasaki disease lacks association with human coronavirus NL63 and human bocavirus. Pediatr Infect Dis J 28(6):553\u2013554. https:\/\/doi.org\/10.1097\/inf.0b013e31819f41b6","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"4832_CR25","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1086\/497170","volume":"192","author":"C Shimizu","year":"2005","unstructured":"Shimizu C, Shike H, Baker SC, Garcia F, van der Hoek L, Kuijpers TW et al (2005) Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis 192(10):1767\u20131771. https:\/\/doi.org\/10.1086\/497170","journal-title":"J Infect Dis"},{"issue":"1","key":"4832_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","volume":"41","author":"J Kabeerdoss","year":"2021","unstructured":"Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S (2021) Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 41(1):19\u201332. https:\/\/doi.org\/10.1007\/s00296-020-04749-4","journal-title":"Rheumatol Int"},{"issue":"10239","key":"4832_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/s0140-6736(20)31103-x","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395(10239):1771\u20131778. https:\/\/doi.org\/10.1016\/s0140-6736(20)31103-x","journal-title":"Lancet"},{"issue":"8","key":"4832_CR28","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","volume":"79","author":"M Pouletty","year":"2020","unstructured":"Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N et al (2020) Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 79(8):999\u20131006. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217960","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4832_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/s2352-4642(20)30175-9","volume":"4","author":"N Ouldali","year":"2020","unstructured":"Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S et al (2020) Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health 4(9):662\u2013668. https:\/\/doi.org\/10.1016\/s2352-4642(20)30175-9","journal-title":"Lancet Child Adolesc Health"},{"key":"4832_CR30","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2020.25.22.2001010","author":"A Belot","year":"2020","unstructured":"Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F et al (2020) SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2020.25.22.2001010","journal-title":"Euro Surveill"},{"issue":"4","key":"4832_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al (2020) Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med 383(4):334\u2013346. https:\/\/doi.org\/10.1056\/NEJMoa2021680","journal-title":"N Engl J Med"},{"issue":"10","key":"4832_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2169\/internalmedicine.48.1718","volume":"48","author":"C Hoshino","year":"2009","unstructured":"Hoshino C (2009) Adult onset Schoenlein-Henoch purpura associated with helicobacter pylori Infection. Intern Med 48(10):847\u2013851. https:\/\/doi.org\/10.2169\/internalmedicine.48.1718","journal-title":"Intern Med"},{"key":"4832_CR33","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2021.037","author":"H Hu","year":"2021","unstructured":"Hu H (2021) Epidemiology and clinical characteristics of Henoch-Sch\u00f6nlein purpura associated with mycoplasma pneumoniae infection in 131 children in Hubei province, China. Mediterranean J Hematol Infect Dis. https:\/\/doi.org\/10.4084\/mjhid.2021.037","journal-title":"Mediterranean J Hematol Infect Dis."},{"issue":"6","key":"4832_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11316120-000000000-00000","volume":"11","author":"K Tullus","year":"2009","unstructured":"Tullus K, Marks SD (2009) Vasculitis in children and adolescents. Pediatr Drugs 11(6):375\u2013380. https:\/\/doi.org\/10.2165\/11316120-000000000-00000","journal-title":"Pediatr Drugs"},{"issue":"6","key":"4832_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00005792-199911000-00005","volume":"78","author":"FT Saulsbury","year":"1999","unstructured":"Saulsbury FT (1999) Henoch-Sch\u00f6nlein purpura in children: report of 100 patients and review of the literature. Medicine 78(6):395\u2013409. https:\/\/doi.org\/10.1097\/00005792-199911000-00005","journal-title":"Medicine"},{"issue":"2 Suppl 41","key":"4832_CR36","first-page":"S71","volume":"24","author":"C Pagnoux","year":"2006","unstructured":"Pagnoux C, Cohen P, Guillevin L (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24(2 Suppl 41):S71-81","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4832_CR37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::Aid-art223>3.0.Co;2-s","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44(6):1313\u20131319. https:\/\/doi.org\/10.1002\/1529-0131(200106)44:6%3c1313::Aid-art223%3e3.0.Co;2-s","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4832_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","volume":"8","author":"S De Vita","year":"2008","unstructured":"De Vita S, Quartuccio L, Fabris M (2008) Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev 8(2):95\u201399. https:\/\/doi.org\/10.1016\/j.autrev.2008.05.005","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4832_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","volume":"46","author":"D S\u00e8ne","year":"2007","unstructured":"S\u00e8ne D, Limal N, Ghillani-Dalbin P, Saadoun D, Piette JC, Cacoub P (2007) Hepatitis C virus-associated B-cell proliferation\u2013the role of serum B lymphocyte stimulator (BLyS\/BAFF). Rheumatology (Oxford) 46(1):65\u201369. https:\/\/doi.org\/10.1093\/rheumatology\/kel177","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4832_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.167.1.21","volume":"167","author":"V Racanelli","year":"2001","unstructured":"Racanelli V, Sansonno D, Piccoli C, D\u2019Amore FP, Tucci FA, Dammacco F (2001) Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 167(1):21\u201329. https:\/\/doi.org\/10.4049\/jimmunol.167.1.21","journal-title":"J Immunol"},{"issue":"3","key":"4832_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2249.2006.03015.x","volume":"143","author":"K Matsubara","year":"2006","unstructured":"Matsubara K, Fukaya T, Miwa K, Shibayama N, Nigami H, Harigaya H et al (2006) Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol 143(3):427\u2013434. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03015.x","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4832_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"D Geetha","year":"2020","unstructured":"Geetha D, Jefferson JA (2020) ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis 75(1):124\u2013137. https:\/\/doi.org\/10.1053\/j.ajkd.2019.04.031","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4832_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1756-185x.13220","volume":"21","author":"MS Lo","year":"2018","unstructured":"Lo MS, Newburger JW (2018) Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis 21(1):64\u201369. https:\/\/doi.org\/10.1111\/1756-185x.13220","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"4832_CR44","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.amjmed.2023.03.028","volume":"136","author":"CG Ahlers","year":"2023","unstructured":"Ahlers CG, Wang B, Howell DN, Choksi V (2023) Extensive palpable purpura preceding renal dysfunction in immunoglobulin a vasculitis due to coronavirus-19 infection. Am J Med 136(7):655\u2013658. https:\/\/doi.org\/10.1016\/j.amjmed.2023.03.028","journal-title":"Am J Med"},{"issue":"5","key":"4832_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.jaad.2019.03.029","volume":"81","author":"M Neufeld","year":"2019","unstructured":"Neufeld M, Molyneux K, Pappelbaum KI, Mayer-Hain S, von Hodenberg C, Ehrchen J et al (2019) Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis. J Am Acad Dermatol 81(5):1078\u20131085. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.029","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4832_CR46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1542\/peds.84.4.666","volume":"84","author":"Y Fujita","year":"1989","unstructured":"Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M et al (1989) Kawasaki disease in families. Pediatrics 84(4):666\u2013669","journal-title":"Pediatrics"},{"issue":"12","key":"4832_CR47","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/INF.0b013e31822ac4ff","volume":"30","author":"A Kottek","year":"2011","unstructured":"Kottek A, Shimizu C, Burns JC (2011) Kawasaki disease in monozygotic twins. Pediatr Infect Dis J 30(12):1114\u20131116. https:\/\/doi.org\/10.1097\/INF.0b013e31822ac4ff","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"4832_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/08035320310002768","volume":"92","author":"R Uehara","year":"2003","unstructured":"Uehara R, Yashiro M, Nakamura Y, Yanagawa H (2003) Kawasaki disease in parents and children. Acta Paediatr 92(6):694\u2013697. https:\/\/doi.org\/10.1080\/08035320310002768","journal-title":"Acta Paediatr"},{"issue":"12","key":"4832_CR49","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archpedi.158.12.1166","volume":"158","author":"R Uehara","year":"2004","unstructured":"Uehara R, Yashiro M, Nakamura Y, Yanagawa H (2004) Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 158(12):1166\u20131169. https:\/\/doi.org\/10.1001\/archpedi.158.12.1166","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"4832_CR50","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpedi.159.9.876","volume":"159","author":"M Dergun","year":"2005","unstructured":"Dergun M, Kao A, Hauger SB, Newburger JW, Burns JC (2005) Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med 159(9):876\u2013881. https:\/\/doi.org\/10.1001\/archpedi.159.9.876","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"4832_CR51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1067\/s0022-3476(03)00502-x","volume":"143","author":"R Gershoni-Baruch","year":"2003","unstructured":"Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Sch\u00f6nlein purpura. J Pediatr 143(5):658\u2013661. https:\/\/doi.org\/10.1067\/s0022-3476(03)00502-x","journal-title":"J Pediatr"},{"issue":"1","key":"4832_CR52","first-page":"69","volume":"33","author":"B Rueda","year":"2006","unstructured":"Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Mart\u00edn J, Gonzalez-Gay MA (2006) Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Sch\u00f6nlein purpura. J Rheumatol 33(1):69\u201373","journal-title":"J Rheumatol"},{"issue":"14","key":"4832_CR53","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/hmg\/ddq176","volume":"19","author":"Y Onouchi","year":"2010","unstructured":"Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T et al (2010) Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 19(14):2898\u20132906. https:\/\/doi.org\/10.1093\/hmg\/ddq176","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4832_CR54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ng.2220","volume":"44","author":"Y Onouchi","year":"2012","unstructured":"Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H et al (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44(5):517\u2013521. https:\/\/doi.org\/10.1038\/ng.2220","journal-title":"Nat Genet"},{"issue":"6","key":"4832_CR55","doi-asserted-by":"publisher","first-page":"e2100256","DOI":"10.1002\/bies.202100256","volume":"44","author":"F Yang","year":"2022","unstructured":"Yang F, Ao X, Ding L, Ye L, Zhang X, Yang L et al (2022) Non-coding RNAs in Kawasaki disease: molecular mechanisms and clinical implications. BioEssays 44(6):e2100256. https:\/\/doi.org\/10.1002\/bies.202100256","journal-title":"BioEssays"},{"key":"4832_CR56","doi-asserted-by":"publisher","first-page":"673294","DOI":"10.3389\/fped.2021.673294","volume":"9","author":"K Sharma","year":"2021","unstructured":"Sharma K, Vignesh P, Srivastava P, Sharma J, Chaudhary H, Mondal S et al (2021) Epigenetics in Kawasaki disease. Front Pediatr 9:673294. https:\/\/doi.org\/10.3389\/fped.2021.673294","journal-title":"Front Pediatr"},{"issue":"3","key":"4832_CR57","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16(3):178\u2013222","journal-title":"Arerugi"},{"key":"4832_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fped.2018.00374","volume":"6","author":"AH Rowley","year":"2018","unstructured":"Rowley AH, Shulman ST (2018) The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr 6:374. https:\/\/doi.org\/10.3389\/fped.2018.00374","journal-title":"Front Pediatr"},{"issue":"Suppl 1","key":"4832_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2249.2011.04361.x","volume":"164","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y (2011) Pathogenesis of Kawasaki disease. Clin Exp Immunol 164(Suppl 1):20\u201322. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04361.x","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"4832_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41390-022-01999-9","volume":"92","author":"M Okabe","year":"2022","unstructured":"Okabe M, Takarada S, Miyao N, Nakaoka H, Ibuki K, Ozawa S et al (2022) G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1. Pediatr Res 92(2):378\u2013387. https:\/\/doi.org\/10.1038\/s41390-022-01999-9","journal-title":"Pediatr Res"},{"key":"4832_CR61","doi-asserted-by":"publisher","first-page":"e11169","DOI":"10.7717\/peerj.11169","volume":"9","author":"C Guo","year":"2021","unstructured":"Guo C, Hua Y, Qian Z (2021) Differentially expressed genes, lncRNAs, and competing endogenous RNAs in Kawasaki disease. PeerJ 9:e11169. https:\/\/doi.org\/10.7717\/peerj.11169","journal-title":"PeerJ"},{"issue":"10","key":"4832_CR62","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G et al (2013) The vascular endothelium and human diseases. Int J Biol Sci 9(10):1057\u20131069. https:\/\/doi.org\/10.7150\/ijbs.7502","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4832_CR63","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41598-020-61667-y","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Hu J, Liu J, Geng Z, Tao Y, Zheng F et al (2020) The role of Ca(2+)\/NFAT in dysfunction and inflammation of human coronary endothelial cells induced by Sera from patients with Kawasaki disease. Sci Rep 10(1):4706. https:\/\/doi.org\/10.1038\/s41598-020-61667-y","journal-title":"Sci Rep"},{"key":"4832_CR64","doi-asserted-by":"publisher","first-page":"43719","DOI":"10.1038\/srep43719","volume":"7","author":"K Ueno","year":"2017","unstructured":"Ueno K, Ninomiya Y, Hazeki D, Masuda K, Nomura Y, Kawano Y (2017) Disruption of endothelial cell homeostasis plays a key role in the early pathogenesis of coronary artery abnormalities in Kawasaki disease. Sci Rep 7:43719. https:\/\/doi.org\/10.1038\/srep43719","journal-title":"Sci Rep"},{"key":"4832_CR65","doi-asserted-by":"publisher","first-page":"106660","DOI":"10.1016\/j.vph.2020.106660","volume":"127","author":"M Xu","year":"2020","unstructured":"Xu M, Qi Q, Men L, Wang S, Li M, Xiao M et al (2020) Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress. Vascul Pharmacol 127:106660. https:\/\/doi.org\/10.1016\/j.vph.2020.106660","journal-title":"Vascul Pharmacol"},{"issue":"10","key":"4832_CR66","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41419-019-2021-3","volume":"10","author":"C Jia","year":"2019","unstructured":"Jia C, Zhang J, Chen H, Zhuge Y, Chen H, Qian F et al (2019) Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1\/RAGE\/cathespin B signaling pathway and NLRP3 inflammasome activation. Cell Death Dis 10(10):778. https:\/\/doi.org\/10.1038\/s41419-019-2021-3","journal-title":"Cell Death Dis"},{"issue":"2","key":"4832_CR67","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/circresaha.116.310233","volume":"120","author":"M He","year":"2017","unstructured":"He M, Chen Z, Martin M, Zhang J, Sangwung P, Woo B et al (2017) miR-483 targeting of CTGF suppresses endothelial-to-mesenchymal transition: therapeutic implications in Kawasaki disease. Circ Res 120(2):354\u2013365. https:\/\/doi.org\/10.1161\/circresaha.116.310233","journal-title":"Circ Res"},{"key":"4832_CR68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biocel.2016.01.011","volume":"72","author":"C Jiang","year":"2016","unstructured":"Jiang C, Fang X, Jiang Y, Shen F, Hu Z, Li X et al (2016) TNF-\u03b1 induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model. Int J Biochem Cell Biol 72:118\u2013124. https:\/\/doi.org\/10.1016\/j.biocel.2016.01.011","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"4832_CR69","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41390-020-1029-9","volume":"92","author":"J Zhao","year":"2022","unstructured":"Zhao J, Chen D (2022) Kawasaki disease: SOCS2-AS1\/miR-324-5p\/CUEDC2 axis regulates the progression of human umbilical vein endothelial cells. Pediatr Res 92(2):388\u2013395. https:\/\/doi.org\/10.1038\/s41390-020-1029-9","journal-title":"Pediatr Res"},{"issue":"2","key":"4832_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21037\/tp-22-7","volume":"11","author":"J Hao","year":"2022","unstructured":"Hao J, Zhang Y, Pan X, Wang H, Li B, You D (2022) Kawasaki disease: lncRNA Slco4a1 regulates the progression of human umbilical vein endothelial cells by targeting the miR-335-5p\/POU5F1 axis. Transl Pediatr 11(2):183\u2013193. https:\/\/doi.org\/10.21037\/tp-22-7","journal-title":"Transl Pediatr"},{"issue":"7476","key":"4832_CR71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature12632","volume":"503","author":"MT Lee","year":"2013","unstructured":"Lee MT, Bonneau AR, Takacs CM, Bazzini AA, DiVito KR, Fleming ES et al (2013) Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition. Nature 503(7476):360\u2013364. https:\/\/doi.org\/10.1038\/nature12632","journal-title":"Nature"},{"issue":"11","key":"4832_CR72","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s13073-014-0102-6","volume":"6","author":"LT Hoang","year":"2014","unstructured":"Hoang LT, Shimizu C, Ling L, Naim AN, Khor CC, Tremoulet AH et al (2014) Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med 6(11):541. https:\/\/doi.org\/10.1186\/s13073-014-0102-6","journal-title":"Genome Med"},{"key":"4832_CR73","doi-asserted-by":"publisher","first-page":"697632","DOI":"10.3389\/fped.2021.697632","volume":"9","author":"L Chang","year":"2021","unstructured":"Chang L, Yang HW, Lin TY, Yang KD (2021) Perspective of immunopathogenesis and immunotherapies for Kawasaki disease. Front Pediatr 9:697632. https:\/\/doi.org\/10.3389\/fped.2021.697632","journal-title":"Front Pediatr"},{"issue":"2","key":"4832_CR74","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/art.39939","volume":"69","author":"M Noval Rivas","year":"2017","unstructured":"Noval Rivas M, Lee Y, Wakita D, Chiba N, Dagvadorj J, Shimada K et al (2017) CD8+ T cells contribute to the development of coronary arteritis in the Lactobacillus casei cell wall extract-induced murine model of Kawasaki disease. Arthritis Rheumatol 69(2):410\u2013421. https:\/\/doi.org\/10.1002\/art.39939","journal-title":"Arthritis Rheumatol"},{"key":"4832_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2016.08.012","volume":"171","author":"Q Ye","year":"2016","unstructured":"Ye Q, Gong FQ, Shang SQ, Hu J (2016) Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease. Clin Immunol 171:25\u201331. https:\/\/doi.org\/10.1016\/j.clim.2016.08.012","journal-title":"Clin Immunol"},{"issue":"1","key":"4832_CR76","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1038\/s41467-021-25771-5","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Xie L, Ding G, Song S, Chen L, Li G et al (2021) Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat Commun 12(1):5444. https:\/\/doi.org\/10.1038\/s41467-021-25771-5","journal-title":"Nat Commun"},{"issue":"1","key":"4832_CR77","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41598-018-36520-y","volume":"9","author":"TM Ko","year":"2019","unstructured":"Ko TM, Chang JS, Chen SP, Liu YM, Chang CJ, Tsai FJ et al (2019) Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease. Sci Rep 9(1):328. https:\/\/doi.org\/10.1038\/s41598-018-36520-y","journal-title":"Sci Rep"},{"key":"4832_CR78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-med-042409-151944","volume":"62","author":"AH Rowley","year":"2011","unstructured":"Rowley AH (2011) Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med 62:69\u201377. https:\/\/doi.org\/10.1146\/annurev-med-042409-151944","journal-title":"Annu Rev Med"},{"key":"4832_CR79","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.2147\/jir.S331727","volume":"14","author":"K Guo","year":"2021","unstructured":"Guo K, Qiu L, Xu Y, Gu X, Zhang L, Lin K et al (2021) Single-nucleotide polymorphism LncRNA AC008392.1\/rs7248320 in CARD8 is associated with Kawasaki disease susceptibility in the Han Chinese population. J Inflamm Res 14:4809\u20134816. https:\/\/doi.org\/10.2147\/jir.S331727","journal-title":"J Inflamm Res"},{"issue":"1","key":"4832_CR80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmii.2011.09.024","volume":"45","author":"MC Teng","year":"2012","unstructured":"Teng MC, Wang LC, Yu HH, Lee JH, Yang YH, Chiang BL (2012) Kawasaki disease and Henoch-Sch\u00f6nlein purpura\u201410 years\u2019 experience of childhood vasculitis at a university hospital in Taiwan. J Microbiol Immunol Infect 45(1):22\u201330. https:\/\/doi.org\/10.1016\/j.jmii.2011.09.024","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"4832_CR81","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1080\/07853890.2021.1969033","volume":"53","author":"M Jiang","year":"2021","unstructured":"Jiang M, Dai J, Yin M, Jiang C, Ren M, Tian L (2021) LncRNA MEG8 sponging miR-181a-5p contributes to M1 macrophage polarization by regulating SHP2 expression in Henoch-Schonlein purpura rats. Ann Med 53(1):1576\u20131588. https:\/\/doi.org\/10.1080\/07853890.2021.1969033","journal-title":"Ann Med"},{"issue":"10","key":"4832_CR82","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.21037\/tp-22-437","volume":"11","author":"L Huang","year":"2022","unstructured":"Huang L, Li Y, Wang P, Xie Y, Liu F, Mao J et al (2022) Integrated analysis of immune- and apoptosis-related lncRNA-miRNA-mRNA regulatory network in children with Henoch Sch\u00f6nlein purpura nephritis. Transl Pediatr 11(10):1682\u20131696. https:\/\/doi.org\/10.21037\/tp-22-437","journal-title":"Transl Pediatr"},{"issue":"15","key":"4832_CR83","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.Can-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77(15):3965\u20133981. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2634","journal-title":"Cancer Res"},{"issue":"4\u20135","key":"4832_CR84","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.autrev.2014.01.031","volume":"13","author":"YH Yang","year":"2014","unstructured":"Yang YH, Yu HH, Chiang BL (2014) The diagnosis and classification of Henoch-Sch\u00f6nlein purpura: an updated review. Autoimmun Rev 13(4\u20135):355\u2013358. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.031","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4832_CR85","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3892\/etm.2021.10454","volume":"22","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Chen J, Wu D, Yan H, Liu F, Xi Y et al (2021) Differential expression of long non-coding RNAs SRA, HCG22 and MHRT in children with Kawasaki disease. Exp Ther Med 22(3):1022. https:\/\/doi.org\/10.3892\/etm.2021.10454","journal-title":"Exp Ther Med"},{"issue":"1","key":"4832_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12887-023-03896-4","volume":"23","author":"Y Xie","year":"2023","unstructured":"Xie Y, Shi H, Han B (2023) Bioinformatic analysis of underlying mechanisms of Kawasaki disease via weighted gene correlation network analysis (WGCNA) and the least absolute shrinkage and selection operator method (LASSO) regression model. BMC Pediatr 23(1):90. https:\/\/doi.org\/10.1186\/s12887-023-03896-4","journal-title":"BMC Pediatr"},{"key":"4832_CR87","doi-asserted-by":"publisher","first-page":"1016575","DOI":"10.3389\/fimmu.2022.1016575","volume":"13","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Xu J, Zhang D, Wu S, Li Z, Zhang J et al (2022) MicroRNAs in Kawasaki disease: an update on diagnosis, therapy and monitoring. Front Immunol 13:1016575. https:\/\/doi.org\/10.3389\/fimmu.2022.1016575","journal-title":"Front Immunol"},{"issue":"12","key":"4832_CR88","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/archdischild-2017-313538","volume":"102","author":"LGY Ho","year":"2017","unstructured":"Ho LGY, Curtis N (2017) What dose of aspirin should be used in the initial treatment of Kawasaki disease? Arch Dis Child 102(12):1180\u20131182. https:\/\/doi.org\/10.1136\/archdischild-2017-313538","journal-title":"Arch Dis Child"},{"issue":"2","key":"4832_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00246-014-1010-7","volume":"36","author":"T Nakada","year":"2015","unstructured":"Nakada T (2015) Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease. Pediatr Cardiol 36(2):335\u2013339. https:\/\/doi.org\/10.1007\/s00246-014-1010-7","journal-title":"Pediatr Cardiol"},{"issue":"12","key":"4832_CR90","doi-asserted-by":"publisher","first-page":"e0144603","DOI":"10.1371\/journal.pone.0144603","volume":"10","author":"HC Kuo","year":"2015","unstructured":"Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH (2015) High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease. PLoS ONE 10(12):e0144603. https:\/\/doi.org\/10.1371\/journal.pone.0144603","journal-title":"PLoS ONE"},{"issue":"1","key":"4832_CR91","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1038\/s41598-022-16398-7","volume":"12","author":"S Alipour","year":"2022","unstructured":"Alipour S, Khalighfard S, Khori V, Amiriani T, Tajaldini M, Dehghan M et al (2022) Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients. Sci Rep 12(1):12054. https:\/\/doi.org\/10.1038\/s41598-022-16398-7","journal-title":"Sci Rep"},{"issue":"5","key":"4832_CR92","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.21037\/tcr-20-2248","volume":"10","author":"M Chen","year":"2021","unstructured":"Chen M, Wu L, Zhan H, Liu T, He Y (2021) Aspirin-induced long non-coding RNA suppresses colon cancer growth. Transl Cancer Res 10(5):2055\u20132069. https:\/\/doi.org\/10.21037\/tcr-20-2248","journal-title":"Transl Cancer Res"},{"key":"4832_CR93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13059-016-0892-5","volume":"17","author":"H Guo","year":"2016","unstructured":"Guo H, Liu J, Ben Q, Qu Y, Li M, Wang Y et al (2016) The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation. Genome Biol 17:24. https:\/\/doi.org\/10.1186\/s13059-016-0892-5","journal-title":"Genome Biol"},{"issue":"14","key":"4832_CR94","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/cells11142256","volume":"11","author":"Y Sun","year":"2022","unstructured":"Sun Y, Liu R, Xia X, Xing L, Jiang J, Bian W et al (2022) Large-scale profiling on lncRNAs in human platelets: correlation with platelet reactivity. Cells 11(14):2256. https:\/\/doi.org\/10.3390\/cells11142256","journal-title":"Cells"},{"issue":"6","key":"4832_CR95","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jaci.2022.07.025","volume":"150","author":"SH Tay","year":"2022","unstructured":"Tay SH, Santosa A, Goh ECH, Xu CX, Wu LH, Bigliardi-Qi M et al (2022) Distinct transcriptomic and metabolomic profiles characterize NSAID-induced urticaria\/angioedema patients undergoing aspirin desensitization. J Allergy Clin Immunol 150(6):1486\u20131497. https:\/\/doi.org\/10.1016\/j.jaci.2022.07.025","journal-title":"J Allergy Clin Immunol"},{"key":"4832_CR96","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2020.08.008","volume":"54","author":"RL Zhang","year":"2020","unstructured":"Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY (2020) Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Curr Opin Pharmacol 54:72\u201381. https:\/\/doi.org\/10.1016\/j.coph.2020.08.008","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"4832_CR97","doi-asserted-by":"publisher","first-page":"Cd014884","DOI":"10.1002\/14651858.CD014884.pub2","volume":"1","author":"C Broderick","year":"2023","unstructured":"Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T (2023) Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database Syst Rev 1(1):Cd014884. https:\/\/doi.org\/10.1002\/14651858.CD014884.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4832_CR98","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13063-022-07051-9","volume":"24","author":"D Eleftheriou","year":"2023","unstructured":"Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R et al (2023) Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Trials 24(1):60. https:\/\/doi.org\/10.1186\/s13063-022-07051-9","journal-title":"Trials"},{"issue":"1","key":"4832_CR99","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12969-019-0337-2","volume":"17","author":"Y Amano","year":"2019","unstructured":"Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N et al (2019) A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease. Pediatr Rheumatol Online J 17(1):34. https:\/\/doi.org\/10.1186\/s12969-019-0337-2","journal-title":"Pediatr Rheumatol Online J"},{"key":"4832_CR100","doi-asserted-by":"publisher","first-page":"3568608","DOI":"10.1155\/2020\/3568608","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xu Y, Zhou H, Wang Y, Li W, Lu Z et al (2020) Association between P2RY12 gene polymorphisms and IVIG resistance in Kawasaki patients. Cardiovasc Ther 2020:3568608. https:\/\/doi.org\/10.1155\/2020\/3568608","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"4832_CR101","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/rheumatology\/key356","volume":"58","author":"JG Ahn","year":"2019","unstructured":"Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS (2019) HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Rheumatology (Oxford) 58(5):770\u2013775. https:\/\/doi.org\/10.1093\/rheumatology\/key356","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4832_CR102","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D et al (2020) Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med 46(6):1958\u20131972. https:\/\/doi.org\/10.3892\/ijmm.2020.4746","journal-title":"Int J Mol Med"},{"issue":"5","key":"4832_CR103","doi-asserted-by":"publisher","first-page":"Cd011188","DOI":"10.1002\/14651858.CD011188.pub3","volume":"5","author":"J Green","year":"2022","unstructured":"Green J, Wardle AJ, Tulloh RM (2022) Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 5(5):Cd011188. https:\/\/doi.org\/10.1002\/14651858.CD011188.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4832_CR104","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14787210.2020.1713752","volume":"18","author":"LS Chang","year":"2020","unstructured":"Chang LS, Kuo HC (2020) The role of corticosteroids in the treatment of Kawasaki disease. Expert Rev Anti Infect Ther 18(2):155\u2013164. https:\/\/doi.org\/10.1080\/14787210.2020.1713752","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"4832_CR105","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","volume":"58","author":"S Ozen","year":"2019","unstructured":"Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T et al (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58(9):1607\u20131616. https:\/\/doi.org\/10.1093\/rheumatology\/kez041","journal-title":"Rheumatology (Oxford)"},{"issue":"24","key":"4832_CR106","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.2174\/0929867324666170920145337","volume":"25","author":"M Lucaf\u00f2","year":"2018","unstructured":"Lucaf\u00f2 M, Stankovic B, Kotur N, Di Silvestre A, Martelossi S, Ventura A et al (2018) Pharmacotranscriptomic biomarkers in glucocorticoid treatment of pediatric inflammatory bowel disease. Curr Med Chem 25(24):2855\u20132871. https:\/\/doi.org\/10.2174\/0929867324666170920145337","journal-title":"Curr Med Chem"},{"key":"4832_CR107","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coph.2020.03.003","volume":"53","author":"AP Syed","year":"2020","unstructured":"Syed AP, Greulich F, Ansari SA, Uhlenhaut NH (2020) Anti-inflammatory glucocorticoid action: genomic insights and emerging concepts. Curr Opin Pharmacol 53:35\u201344. https:\/\/doi.org\/10.1016\/j.coph.2020.03.003","journal-title":"Curr Opin Pharmacol"},{"issue":"20","key":"4832_CR108","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/1873-3468.14409","volume":"596","author":"BA Strickland","year":"2022","unstructured":"Strickland BA, Ansari SA, Dantoft W, Uhlenhaut NH (2022) How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids. FEBS Lett 596(20):2596\u20132616. https:\/\/doi.org\/10.1002\/1873-3468.14409","journal-title":"FEBS Lett"},{"key":"4832_CR109","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd9923","author":"H Zhu","year":"2021","unstructured":"Zhu H, Li J, Li Y, Zheng Z, Guan H, Wang H et al (2021) Glucocorticoid counteracts cellular mechanoresponses by LINC01569-dependent glucocorticoid receptor-mediated mRNA decay. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abd9923","journal-title":"Sci Adv"},{"issue":"11","key":"4832_CR110","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1111\/jcmm.16510","volume":"25","author":"G Li","year":"2021","unstructured":"Li G, Li B, Li B, Zhao J, Wang X, Luo R et al (2021) The role of biomechanical forces and MALAT1\/miR-329-5p\/PRIP signalling on glucocorticoid-induced osteonecrosis of the femoral head. J Cell Mol Med 25(11):5164\u20135176. https:\/\/doi.org\/10.1111\/jcmm.16510","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4832_CR111","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pulmoe.2019.07.001","volume":"26","author":"JH Liu","year":"2020","unstructured":"Liu JH, Li C, Zhang CH, Zhang ZH (2020) LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K\/AKT signaling pathway by targeting miR-21 in severe asthma. Pulmonology 26(1):18\u201326. https:\/\/doi.org\/10.1016\/j.pulmoe.2019.07.001","journal-title":"Pulmonology"},{"issue":"23","key":"4832_CR112","doi-asserted-by":"publisher","first-page":"25408","DOI":"10.18632\/aging.203757","volume":"13","author":"X Pei","year":"2021","unstructured":"Pei X, Wen Y, Cui F, Yang Z, Xie Z (2021) lncRNA CASC7 regulates pathological progression of ox-LDL-stimulated atherosclerotic cell models via sponging miR-21 and regulating PI3K\/Akt and TLR4\/NF-\u03baB signaling pathways. Aging (Albany, NY) 13(23):25408\u201325425. https:\/\/doi.org\/10.18632\/aging.203757","journal-title":"Aging (Albany, NY)"},{"key":"4832_CR113","doi-asserted-by":"publisher","first-page":"1005944","DOI":"10.3389\/fendo.2022.1005944","volume":"13","author":"Y Su","year":"2022","unstructured":"Su Y, Chen X, Zhou H, Shaw S, Chen J, Isales CM et al (2022) Expression of long noncoding RNA Xist is induced by glucocorticoids. Front Endocrinol (Lausanne) 13:1005944. https:\/\/doi.org\/10.3389\/fendo.2022.1005944","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4832_CR114","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1038\/s41598-019-44827-7","volume":"9","author":"F Mirzadeh Azad","year":"2019","unstructured":"Mirzadeh Azad F, Malakootian M, Mowla SJ (2019) lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells. Sci Rep 9(1):8370. https:\/\/doi.org\/10.1038\/s41598-019-44827-7","journal-title":"Sci Rep"},{"issue":"1","key":"4832_CR115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.33549\/physiolres.934672","volume":"71","author":"MA Bordea","year":"2022","unstructured":"Bordea MA, Costache C, Grama A, Florian AI, Lupan I, Samasca G et al (2022) Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol Res 71(1):17\u201327. https:\/\/doi.org\/10.33549\/physiolres.934672","journal-title":"Physiol Res"},{"issue":"8","key":"4832_CR116","doi-asserted-by":"publisher","first-page":"Cd012448","DOI":"10.1002\/14651858.CD012448.pub2","volume":"8","author":"N Yamaji","year":"2019","unstructured":"Yamaji N, da Silva LK, Shoda T, Ishitsuka K, Kobayashi T, Ota E et al (2019) TNF-\u03b1 blockers for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 8(8):Cd012448. https:\/\/doi.org\/10.1002\/14651858.CD012448.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"4832_CR117","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1212\/wnl.0000000000201472","volume":"100","author":"L Li","year":"2023","unstructured":"Li L, Avi\u00f1a-Zubieta JA, Bernstein CN, Kaplan GG, Tremlett H, Xie H et al (2023) Risk of multiple sclerosis among users of antitumor necrosis factor \u03b1 in 4 Canadian Provinces: a population-based study. Neurology 100(6):e558\u2013e567. https:\/\/doi.org\/10.1212\/wnl.0000000000201472","journal-title":"Neurology"},{"issue":"3","key":"4832_CR118","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.1313768111","volume":"111","author":"Z Li","year":"2014","unstructured":"Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C et al (2014) The long noncoding RNA THRIL regulates TNF\u03b1 expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111(3):1002\u20131007. https:\/\/doi.org\/10.1073\/pnas.1313768111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4832_CR119","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/cbin.11934","volume":"47","author":"X Song","year":"2023","unstructured":"Song X, Gao F, Li H, Qin W, Chai C, Shi G et al (2023) Long noncoding RNA THRIL promotes foam cell formation and inflammation in macrophages. Cell Biol Int 47(1):156\u2013166. https:\/\/doi.org\/10.1002\/cbin.11934","journal-title":"Cell Biol Int"},{"issue":"1","key":"4832_CR120","doi-asserted-by":"publisher","first-page":"e21133","DOI":"10.1096\/fj.202001654RR","volume":"35","author":"H Zhou","year":"2021","unstructured":"Zhou H, Simion V, Pierce JB, Haemmig S, Chen AF, Feinberg MW (2021) LncRNA-MAP3K4 regulates vascular inflammation through the p38 MAPK signaling pathway and cis-modulation of MAP3K4. Faseb j 35(1):e21133. https:\/\/doi.org\/10.1096\/fj.202001654RR","journal-title":"Faseb j"},{"issue":"5","key":"4832_CR121","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ped.12120","volume":"55","author":"C Suzuki","year":"2013","unstructured":"Suzuki C, Yahata T, Okamoto-Hamaoka A, Fujii M, Yoshioka A, Niwa Y et al (2013) Utility of whole-blood aggregometry for evaluating anti-platelet therapy for Kawasaki disease. Pediatr Int 55(5):550\u2013554. https:\/\/doi.org\/10.1111\/ped.12120","journal-title":"Pediatr Int"},{"issue":"1","key":"4832_CR122","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1080\/22221751.2020.1785336","volume":"9","author":"JM Berthelot","year":"2020","unstructured":"Berthelot JM, Drouet L, Liot\u00e9 F (2020) Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? Emerg Microbes Infect 9(1):1514\u20131522. https:\/\/doi.org\/10.1080\/22221751.2020.1785336","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"4832_CR123","doi-asserted-by":"publisher","first-page":"e3309","DOI":"10.5812\/ijp.3309","volume":"25","author":"I Malekzadeh","year":"2015","unstructured":"Malekzadeh I, Ziaee V, Sadrosadat T, Moardinejad MH, Sayadpour-Zanjani K (2015) Kawasaki disease and peripheral gangrene in infancy. Iran J Pediatr 25(6):e3309. https:\/\/doi.org\/10.5812\/ijp.3309","journal-title":"Iran J Pediatr"},{"issue":"3","key":"4832_CR124","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/0004563217727015","volume":"55","author":"X Shi","year":"2018","unstructured":"Shi X, Li WC, Mo LJ, Li XH, Luo YZ, Qin LQ et al (2018) Altered mean platelet volume in children with Henoch-Schonlein purpura and its association with disease activity. Ann Clin Biochem 55(3):368\u2013372. https:\/\/doi.org\/10.1177\/0004563217727015","journal-title":"Ann Clin Biochem"},{"issue":"10","key":"4832_CR125","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2169\/internalmedicine.52.9325","volume":"52","author":"H Ishiguro","year":"2013","unstructured":"Ishiguro H, Hashimoto T, Akata M, Suzuki S, Azushima K, Kobayashi Y et al (2013) Rituximab treatment for adult purpura nephritis with nephrotic syndrome. Intern Med 52(10):1079\u20131083. https:\/\/doi.org\/10.2169\/internalmedicine.52.9325","journal-title":"Intern Med"},{"issue":"1","key":"4832_CR126","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12887-022-03151-2","volume":"22","author":"D van Stijn","year":"2022","unstructured":"van Stijn D, Schoenmaker NJ, Planken RN, Koolbergen DR, Gouw SC, Kuijpers TW et al (2022) Myocardial infarction due to thrombotic occlusion despite anticoagulation in Kawasaki disease\u2014a case report. BMC Pediatr 22(1):85. https:\/\/doi.org\/10.1186\/s12887-022-03151-2","journal-title":"BMC Pediatr"},{"issue":"20","key":"4832_CR127","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.3390\/ijms21207614","volume":"21","author":"CT Neu","year":"2020","unstructured":"Neu CT, Gutschner T, Haemmerle M (2020) Post-transcriptional expression control in platelet biogenesis and function. Int J Mol Sci 21(20):7614. https:\/\/doi.org\/10.3390\/ijms21207614","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4832_CR128","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/ijlh.13261","volume":"42","author":"S Yan","year":"2020","unstructured":"Yan S, Liu X, Ke X, Xian Z, Peng C, Wang X et al (2020) Screening on platelet LncRNA expression profile discloses novel residual platelet reactivity biomarker. Int J Lab Hematol 42(5):661\u2013668. https:\/\/doi.org\/10.1111\/ijlh.13261","journal-title":"Int J Lab Hematol"},{"issue":"23","key":"4832_CR129","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood.2019004119","volume":"137","author":"S Lazar","year":"2021","unstructured":"Lazar S, Goldfinger LE (2021) Platelets and extracellular vesicles and their cross talk with cancer. Blood 137(23):3192\u20133200. https:\/\/doi.org\/10.1182\/blood.2019004119","journal-title":"Blood"},{"issue":"3","key":"4832_CR130","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molcel.2017.06.020","volume":"67","author":"M Morchikh","year":"2017","unstructured":"Morchikh M, Cribier A, Raffel R, Amraoui S, Cau J, Severac D et al (2017) HEXIM1 and NEAT1 long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response. Mol Cell 67(3):387\u201399.e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.020","journal-title":"Mol Cell"},{"issue":"5","key":"4832_CR131","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/chd.12502","volume":"12","author":"JW Newburger","year":"2017","unstructured":"Newburger JW (2017) Kawasaki disease: medical therapies. Congenit Heart Dis 12(5):641\u2013643. https:\/\/doi.org\/10.1111\/chd.12502","journal-title":"Congenit Heart Dis"},{"issue":"21","key":"4832_CR132","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K et al (2021) Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial. JAMA 325(21):2178\u20132187. https:\/\/doi.org\/10.1001\/jama.2021.6615","journal-title":"JAMA"},{"issue":"1","key":"4832_CR133","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12969-021-00526-0","volume":"19","author":"O Halyabar","year":"2021","unstructured":"Halyabar O, Friedman KG, Sundel RP, Baker AL, Chang MH, Gould PW et al (2021) Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J 19(1):31. https:\/\/doi.org\/10.1186\/s12969-021-00526-0","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"4832_CR134","doi-asserted-by":"publisher","first-page":"Cd005128","DOI":"10.1002\/14651858.CD005128.pub4","volume":"2","author":"D Hahn","year":"2023","unstructured":"Hahn D, Hodson EM, Craig JC (2023) Interventions for preventing and treating kidney disease in IgA vasculitis. Cochrane Database Syst Rev 2(2):Cd005128. https:\/\/doi.org\/10.1002\/14651858.CD005128.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"4832_CR135","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF et al (2003) Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 101(5):2043\u20132048. https:\/\/doi.org\/10.1182\/blood-2002-06-1860","journal-title":"Blood"},{"issue":"6","key":"4832_CR136","doi-asserted-by":"publisher","first-page":"Cd002922","DOI":"10.1002\/14651858.CD002922.pub4","volume":"6","author":"DJ Tunnicliffe","year":"2018","unstructured":"Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A et al (2018) Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database Syst Rev 6(6):Cd002922. https:\/\/doi.org\/10.1002\/14651858.CD002922.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"4832_CR137","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1200\/jco.2010.31.4187","volume":"29","author":"U Vitolo","year":"2011","unstructured":"Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M et al (2011) First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol 29(20):2766\u20132772. https:\/\/doi.org\/10.1200\/jco.2010.31.4187","journal-title":"J Clin Oncol"},{"issue":"11","key":"4832_CR138","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/15592294.2019.1631111","volume":"14","author":"G Di Emidio","year":"2019","unstructured":"Di Emidio G, D\u2019Aurora M, Placidi M, Franchi S, Rossi G, Stuppia L et al (2019) Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects. Epigenetics 14(11):1057\u20131064. https:\/\/doi.org\/10.1080\/15592294.2019.1631111","journal-title":"Epigenetics"},{"issue":"9","key":"4832_CR139","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00011-022-01604-z","volume":"71","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wang Z, Xu Y, Liu X, Sun Y, Li W (2022) Knockdown of lncRNA H19 alleviates ox-LDL-induced HCAECs inflammation and injury by mediating miR-20a-5p\/HDAC4 axis. Inflamm Res 71(9):1109\u20131121. https:\/\/doi.org\/10.1007\/s00011-022-01604-z","journal-title":"Inflamm Res"},{"key":"4832_CR140","doi-asserted-by":"publisher","first-page":"152439","DOI":"10.1016\/j.tox.2020.152439","volume":"437","author":"RM Salama","year":"2020","unstructured":"Salama RM, Abd Elwahab AH, Abd-Elgalil MM, Elmongy NF, Schaalan MF (2020) LCZ696 (sacubitril\/valsartan) protects against cyclophosphamide-induced testicular toxicity in rats: Role of neprilysin inhibition and lncRNA TUG1 in ameliorating apoptosis. Toxicology 437:152439. https:\/\/doi.org\/10.1016\/j.tox.2020.152439","journal-title":"Toxicology"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04832-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:44:52Z","timestamp":1724435092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04832-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":140,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4832"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04832-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}